This report uses the CB Insights MVP Technology Framework to rank tech market planning decisions and give an adoption playbook for the clinical trials domain.
CB Insights examined tech markets across clinical trials using the MVP framework. This methodology scores top tech markets across two metrics:
Market momentum — Measures private market activity as a signal of the degree of overall market potential. Signals include the number of startups, the amount of capital invested, and the relative maturity of startups in the space, among others.
Industry leader activity — Assesses the degree of tech market involvement among established industry players. Signals include CVC activity, industry and executive chatter, and patent filings, among others.
Leaders from pharmaceutical companies (sponsors) and contract research organizations (investigators) are shifting more of their R&D budgets toward transformational innovation, focusing on novel technologies that can improve the quality and cost of clinical trials and address unmet market needs.
In this report, we evaluate 8 tech markets that sponsors and investigators should monitor, vet, and prioritize toward this effort, including:
- Real-world data
- Patient recruitment & enrollment
- Decentralized clinical trials
- Digital twins & biosimulations
- Data & quality management
Want the full expert post? Become a CB Insights customer.
If you’re already a customer, log in here.
